daunorubicin has been researched along with phytoestrogens in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gayer, B; Hodge, RP; Kalchenko, V; Katzburg, S; Kohen, F; Meshorer, A; Nevo, N; Renevey, MD; Somjen, D; Stern, N | 1 |
| Ha, I; Han, HK; Im, YB; Kang, KW; Lee, MY | 1 |
2 other study(ies) available for daunorubicin and phytoestrogens
| Article | Year |
|---|---|
A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Daunorubicin; Female; Humans; Isoflavones; Mice; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Phytoestrogens; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Macelignan: a new modulator of P-glycoprotein in multidrug-resistant cancer cells.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorescent Dyes; Growth Inhibitors; Humans; Lignans; Phytoestrogens; Phytotherapy; Rhodamine 123; Vinblastine | 2009 |